Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 5 | 132672844 | upstream gene variant | G/A | snv | 3.7E-03 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.060 | 1.000 | 6 | 2012 | 2016 | |||||||
|
0.672 | 0.560 | 5 | 132674018 | 5 prime UTR variant | C/T | snv | 0.28 | 0.28 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.050 | 1.000 | 5 | 2011 | 2016 | ||||||
|
0.732 | 0.480 | 5 | 132677033 | intron variant | T/C;G | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.030 | 1.000 | 3 | 2013 | 2015 | ||||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Immune System Diseases; Nervous System Diseases | 0.030 | 0.667 | 3 | 2007 | 2019 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.030 | 0.667 | 3 | 2013 | 2018 | |||||||
|
0.672 | 0.560 | 5 | 132674018 | 5 prime UTR variant | C/T | snv | 0.28 | 0.28 |
|
Infections; Respiratory Tract Diseases | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||||
|
0.672 | 0.560 | 5 | 132674018 | 5 prime UTR variant | C/T | snv | 0.28 | 0.28 |
|
Digestive System Diseases; Infections | 0.020 | 1.000 | 2 | 2012 | 2013 | ||||||
|
0.672 | 0.560 | 5 | 132674018 | 5 prime UTR variant | C/T | snv | 0.28 | 0.28 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||||
|
0.672 | 0.560 | 5 | 132674018 | 5 prime UTR variant | C/T | snv | 0.28 | 0.28 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||||
|
0.732 | 0.480 | 5 | 132677033 | intron variant | T/C;G | snv |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.020 | 1.000 | 2 | 2013 | 2018 | ||||||||
|
0.763 | 0.240 | 5 | 132672952 | upstream gene variant | T/A;C;G | snv |
|
Neoplasms | 0.020 | 1.000 | 2 | 2007 | 2015 | ||||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2013 | 2017 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2017 | 2018 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2011 | 2015 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2010 | 2017 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2010 | 2017 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 1.000 | 2 | 2014 | 2017 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms; Respiratory Tract Diseases | 0.020 | 0.500 | 2 | 2015 | 2019 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2011 | 2012 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms | 0.020 | 0.500 | 2 | 2013 | 2017 | |||||||
|
0.570 | 0.760 | 5 | 132673462 | upstream gene variant | C/T | snv | 0.35 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2013 | 2017 |